THC
17.5–20.1%
CBD
0.1%
Kamikhaze is a Venus Genetics sativa testing 18-20% THC, with flavor and effect details still unpublished.
No effect, terpene, flavor or medical-use data specific to Kamikhaze has been published yet, so we don't guess. For what sativa strains usually do, see the effects guide.
THC in this profile
20.1% THC
About Kamikhaze
Venus Genetics offers this sativa at a THC range of roughly 18 to 20 percent, solidly strong without reaching the most extreme figures on the market. The name suggests a fast, disorienting rush, though no effect, flavor, or lineage information has actually been published to back that impression - what's confirmed is simply the sativa category, the breeder, and that potency window. Venus Genetics also carries other strains in circulation, and this one's data sheet follows a similar pattern of leading with THC while leaving flowering time, yield, and terpene details for growers to discover firsthand. For buyers drawn to the name and the number alone, that 18-to-20-percent range is a reasonably dependable signal of strength, even without a fuller profile to explain the flavor or high that comes with it.
Where to Buy Seeds
We may earn a commission from purchases made through these links.
Frequently Asked Questions about Kamikhaze
Is Kamikhaze an Indica, Sativa, or Hybrid?
Kamikhaze is classified as a sativa cannabis strain.
What cannabinoid content is reported for Kamikhaze?
Kamikhaze: 20.1% THC and 0.1% CBD reported in our data. The THC figure, when present, is the upper end of the reported range, not a typical measured dose. Potency can vary across harvests, phenotypes, and growing conditions.